ID: ALA4472461

Max Phase: Preclinical

Molecular Formula: C29H35FN4O9

Molecular Weight: 602.62

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C1C(=O)O[C@H]2[C@H]1CC/C(COC(=O)CCC(=O)N1CCN(C(=O)Cn3cc(F)c(=O)[nH]c3=O)CC1)=C\CC[C@@]1(C)O[C@@H]21

Standard InChI:  InChI=1S/C29H35FN4O9/c1-17-19-6-5-18(4-3-9-29(2)25(43-29)24(19)42-27(17)39)16-41-23(37)8-7-21(35)32-10-12-33(13-11-32)22(36)15-34-14-20(30)26(38)31-28(34)40/h4,14,19,24-25H,1,3,5-13,15-16H2,2H3,(H,31,38,40)/b18-4+/t19-,24-,25-,29+/m0/s1

Standard InChI Key:  OFIFYYMGHYMFLA-DNAUFTMUSA-N

Associated Targets(Human)

Bel7402/5-FU 373 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bel-7402 4577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 602.62Molecular Weight (Monoisotopic): 602.2388AlogP: 0.43#Rotatable Bonds: 7
Polar Surface Area: 160.61Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.12CX Basic pKa: CX LogP: 0.04CX LogD: -0.03
Aromatic Rings: 1Heavy Atoms: 43QED Weighted: 0.20Np Likeness Score: 0.79

References

1. Ding Y, Li S, Ge W, Liu Z, Zhang X, Wang M, Chen T, Chen Y, Zhang Q..  (2019)  Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.,  183  [PMID:31553932] [10.1016/j.ejmech.2019.111706]

Source